SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Vistagen (Nasdaq: VTGN), a late clinical-stage company dedicated to pioneering neuroscience based on nose-to-brain neurocircuitry, today announced ...

Risk-sharing agreements incentivize high-quality diabetes care by linking reimbursement to value-based outcomes, addressing social determinants of health. Continuous glucose monitoring (CGM) is ...

Viking Therapeutics completes enrollment in a phase I maintenance study of VK2735, testing flexible oral and injectable ...

Capivasertib (C) and fulvestrant (F) for patients (pts) with aromatase inhibitor (AI)-resistant HR+/HER2– advanced breast cancer (ABC): Characterization and management of common adverse events (AEs) ...

In a recent study published in the journal Mindfulness, researchers examine the prevalence and effects of emergent phenomena (EP), their forms, the balance of positive and negative repercussions, and ...